These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11605086)

  • 1. The GABA(A) agonist gaboxadol improves the quality of post-nap sleep.
    Mathias S; Steiger A; Lancel M
    Psychopharmacology (Berl); 2001 Sep; 157(3):299-304. PubMed ID: 11605086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
    Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
    Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia.
    Dijk DJ; Stanley N; Lundahl J; Groeger JA; Legters A; Trap Huusom AK; Deacon S
    J Psychopharmacol; 2012 Aug; 26(8):1096-107. PubMed ID: 22002961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors.
    Winsky-Sommerer R; Vyazovskiy VV; Homanics GE; Tobler I
    Eur J Neurosci; 2007 Mar; 25(6):1893-9. PubMed ID: 17408425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
    Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
    Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-aminobutyric Acid(A) (GABA(A)) agonist 4,5,6, 7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats.
    Lancel M; Langebartels A
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1084-90. PubMed ID: 10869413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the GABAA agonist gaboxadol on nocturnal sleep and hormone secretion in healthy elderly subjects.
    Lancel M; Wetter TC; Steiger A; Mathias S
    Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E130-7. PubMed ID: 11404230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.
    Dijk DJ; James LM; Peters S; Walsh JK; Deacon S
    J Psychopharmacol; 2010 Nov; 24(11):1613-8. PubMed ID: 19487320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
    Mathias S; Zihl J; Steiger A; Lancel M
    Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia.
    Lundahl J; Deacon S; Maurice D; Staner L
    J Psychopharmacol; 2012 Aug; 26(8):1081-7. PubMed ID: 22057018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaboxadol, a selective extrasynaptic GABA(A) agonist, does not generalise to other sleep-enhancing drugs: a rat drug discrimination study.
    McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
    Neuropharmacology; 2007 Mar; 52(3):844-53. PubMed ID: 17196996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
    Walsh JK; Deacon S; Dijk DJ; Lundahl J
    Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaboxadol--a new awakening in sleep.
    Wafford KA; Ebert B
    Curr Opin Pharmacol; 2006 Feb; 6(1):30-6. PubMed ID: 16368265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia.
    Lundahl J; Staner L; Staner C; Loft H; Deacon S
    Psychopharmacology (Berl); 2007 Nov; 195(1):139-46. PubMed ID: 17653697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
    Lankford DA; Corser BC; Zheng YP; Li Z; Snavely DB; Lines CR; Deacon S
    Sleep; 2008 Oct; 31(10):1359-70. PubMed ID: 18853933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alcohol on polysomnographically recorded sleep in healthy subjects.
    Feige B; Gann H; Brueck R; Hornyak M; Litsch S; Hohagen F; Riemann D
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1527-37. PubMed ID: 16930215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
    Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
    Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
    Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
    Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GABAA agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat.
    Lancel M; Faulhaber J
    Neuroreport; 1996 Sep; 7(13):2241-5. PubMed ID: 8930997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.